Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2014;20(1):38-46. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.38

View: 9042 Download: 83 Web of Science: 32 Crossref: 31

The secondary prophylactic efficacy of beta-blocker after endoscopic gastric variceal obturation for first acute episode of gastric variceal bleeding

Moon Han Choi, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Yu Ri Seo, Min Jin Kim, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2013;19(3):280-287. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.280

View: 7887 Download: 57 Crossref: 6

The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis

Jong Ho Chung, Hyung Su Ahn, Sang Gyune Kim, Yun Nah Lee, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2013;19(2):156-164. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.156

View: 10501 Download: 123 Crossref: 30

Case Report

Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C

Jae Hee Lim, Yun Nah Lee, Young Seok Kim, Sang Gyune Kim, Seung Won Jeong, Jae Young Jang, Hong Soo Kim, Sae Hwan Lee, Tae Kwann Park

Clin Mol Hepatol. 2011;17(1):61-65. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.61

View: 8893 Download: 50 Crossref: 11

1 |

Viewed By 5240	MAFLD: How is it different from NAFLD?
Viewed By 4997	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4905	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4672	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4650	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 162	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 136	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 120	MAFLD: How is it different from NAFLD?
Cited By 98	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search